Managers

Endowment Wealth Management targets $25 mln for unicorn tech fund

Appleton, Wisconsin-based Endowment Wealth Management Inc, an investment adviser, is seeking to raise up to $25 million for its unicorn technology fund. The fund will focus on late-stage, venture-backed tech companies in the secondary market. Currently, the fund has made six undisclosed investments in this space.

VC Video Interview: Don't fear the 'robopocalypse'

Data spotlight: NEA, Greycroft, Accel rank as most active VCs in Q3

Columbus Venture Partners and AskBio launch gene therapy joint venture

AskBio and Columbus Venture Partners have formed Viralgen, a gene therapy joint venture. In addition to funding from AskBio and Columbus Venture Partners, Viralgen, which will be based in San Sebastián, Spain, has secured a "significant" commitment from the Basque Government. No financial terms were disclosed.

Imaginary Ventures seeks $100 mln for inaugural e-commerce fund

New York-based Imaginary Ventures is seeking $100 million for its debut, according to a regulatory filing. The firm will reportedly invest in the e-commerce space, including retail, fashion, lifestyle and beauty. The firm is led by Natalie Massenet, who in 2015 resigned from luxury e-tailer Net-A-Porter that she founded, and Nick Brown, who most recently was a partner at 14W Venture Partners in New York.

Blockchain Capital raises $60 mln of targeted $75 mln fourth fund

San Francisco-based Blockchain Capital has raised $59,720,000 of a targeted $75 million fourth fund, according to a regulatory filing. The firm is led by brothers Brad and Bart Stephens and focuses on investments into blockchain technologies. Thus far, 76 investors have committed to the fund, according to the filing. In April, the firm raised $10 million of its third fund through an initial coin offering, or ICO, VCJ previously reported.

Cydan nabs $34 mln

Cambridge, Massachusetts-based Cydan, an orphan drug accelerator, has raised $34 million in funding. The investors were Longitude Capital, New Enterprise Associates, Pfizer Venture Investments, Alexandria Venture Investments and Lundbeckfond Ventures.

Next Frontier Capital collects $22 mln for sophomore fund

Next Frontier Capital has raised $22 million for its second fund. The current target is $30 million. Based in Bozeman, Montana, the venture firm backs tech companies that are in the state.

Precision medicine company Gemini Therapeutics attracts $42.5 mln

Cambridge, Massachusetts-based Gemini Therapeutics, a new precision medicine company , has closed $42.5 million in Series A financing. Atlas Venture, Lightstone Ventures and OrbiMed led the round.

Tamarisc targets $30 mln for sophomore fund

Tamarisc Ventures is seeking to raise $30 million for its second fund, according to an SEC listing. The Cambridge, Massachusetts-based early-stage venture firm invests in real estate technology companies.